Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 3/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 2/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6123631 | 0.89 | ACHE (0.34) | ACHEESR1ESR2KDM4ERCE1 | |
| SCHEMBL6123562 | 0.84 | ACHE (0.35) | ACHEKDM4ERCE1MAPT | |
| SCHEMBL6123605 | 0.82 | ACHE (0.31) | ACHE | |
| SCHEMBL6123567 | 0.79 | ACHE (0.36) | ACHEKDM4ERCE1PDE4APDE4B | |
| SCHEMBL6123516 | 0.78 | PTAFR (0.33) | ACHEKDM4ERCE1MAPT | |
| SCHEMBL6123632 | 0.78 | — | — | |
| SCHEMBL25056917 | 0.77 | ALDH1A1 (0.45) | ALOX5KDM4EPDE4APDE4BPDE4C | |
| SCHEMBL18801565 | 0.77 | ALDH1A1 (0.45) | ALOX5KDM4EPDE4APDE4BPDE4C | |
| SCHEMBL26318179 | 0.76 | KMT2A (0.38) | KDM4ERCE1MAPT | |
| SCHEMBL26318464 | 0.76 | KMT2A (0.38) | KDM4ERCE1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173272-B2 | Diamine derivatives, preparation method thereof and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-05-08 | — | — | US | disclosed |
| US-8173272-B2 | Diamine derivatives, preparation method thereof and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-05-08 | — | — | US | disclosed |
| US-20090134781-A1 | Diamine Derivatives, Preparation Method Thereof and Organic Electronic Device Using the Same | LG CHEM, LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
| US-20090134781-A1 | Diamine Derivatives, Preparation Method Thereof and Organic Electronic Device Using the Same | LG CHEM, LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090134781-A1 | Diamine Derivatives, Preparation Method Thereof and Organic Electronic Device Using the Same | DDT, AOC1, DDC | ACHE 688/4885ALOX5 1831/4885ESR1 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.